385 related articles for article (PubMed ID: 6304866)
1. Myeloperoxidase-deficient polymorphonuclear leucocytes. (I) Incidence in untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
Bendix-Hansen K; Kaspersen Nielsen H
Scand J Haematol; 1983 May; 30(5):415-9. PubMed ID: 6304866
[TBL] [Abstract][Full Text] [Related]
2. Myeloperoxidase deficient polymorphonuclear leucocytes in leukaemia and allied disorders.
Bendix-Hansen K
Dan Med Bull; 1988 Dec; 35(6):501-20. PubMed ID: 2851415
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-deficient polymorphonuclear leucocytes. (II) Longitudinal study in acute myeloid leukaemia, untreated, in remission and in relapse.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1983 Jul; 31(1):5-8. PubMed ID: 6306759
[TBL] [Abstract][Full Text] [Related]
4. Myeloperoxidase-deficient polymorphonuclear leucocytes (III): Relation to incidence of infection in acute myeloid leukaemia.
Nielsen HK; Bendix-Hansen K
Scand J Haematol; 1984 Jul; 33(1):75-9. PubMed ID: 6087443
[TBL] [Abstract][Full Text] [Related]
5. Myeloperoxidase-deficient polymorphonuclear leucocytes. (IV): Relation to FAB-classification in acute myeloid leukaemia.
Bendix-Hansen K; Nielsen HK
Scand J Haematol; 1985 Aug; 35(2):174-7. PubMed ID: 2996122
[TBL] [Abstract][Full Text] [Related]
6. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
[TBL] [Abstract][Full Text] [Related]
7. Myeloperoxidase-deficient polymorphonuclear leucocytes (VII): Incidence in untreated myeloproliferative disorders.
Bendix-Hansen K
Scand J Haematol; 1986 Jan; 36(1):8-10. PubMed ID: 3006224
[TBL] [Abstract][Full Text] [Related]
8. Myeloperoxidase-deficient polymorphonuclear leucocytes. Longitudinal study during the preremission--and the remission phase in acute myeloid leukaemia. Comparison to neutrophil alkaline phosphatase (NAP) activity.
Bendix-Hansen K
Blut; 1986 Apr; 52(4):237-42. PubMed ID: 3008894
[TBL] [Abstract][Full Text] [Related]
9. Myeloperoxidase deficient polymorphonuclear leucocytes: computerized planimetric estimations of cellular and nuclear size.
Bendix-Hansen K
Virchows Arch B Cell Pathol Incl Mol Pathol; 1986; 52(4):319-25. PubMed ID: 2883756
[TBL] [Abstract][Full Text] [Related]
10. Abnormal pattern of bactericidal activity of neutrophils deficient in granules, myeloperoxidase, and alkaline phosphatase.
Repine JE; Clawson CC; Brunning RD
J Lab Clin Med; 1976 Nov; 88(5):788-95. PubMed ID: 185307
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil myeloperoxidase: a simple, reproducible technique to determine activity.
Kitahara M; Simonian Y; Eyre HJ
J Lab Clin Med; 1979 Feb; 93(2):232-7. PubMed ID: 219116
[TBL] [Abstract][Full Text] [Related]
12. Myeloperoxidase modulates the phagocytic activity of polymorphonuclear neutrophil leukocytes. Studies with cells from a myeloperoxidase-deficient patient.
Stendahl O; Coble BI; Dahlgren C; Hed J; Molin L
J Clin Invest; 1984 Feb; 73(2):366-73. PubMed ID: 6321554
[TBL] [Abstract][Full Text] [Related]
13. Partial myeloperoxidase deficiency in a case of preleukaemia. II. Defects of degranulation and abnormal bactericidal activity of blood neutrophils.
Breton-Gorius J; Houssay D; Vilde JL; Dreyfus B
Br J Haematol; 1975 Jul; 30(3):279-88. PubMed ID: 172112
[TBL] [Abstract][Full Text] [Related]
14. Myeloperoxidase-deficient neutrophils in chronic myelocytic leukemia.
Dallegri F; Mela G; Patrone F
Haematologica; 1978 Apr; 63(2):163-7. PubMed ID: 210090
[No Abstract] [Full Text] [Related]
15. Increased degranulation of human myeloperoxidase-deficient polymorphonuclear leucocytes.
Dri P; Cramer R; Menegazzi R; Patriarca P
Br J Haematol; 1985 Jan; 59(1):115-25. PubMed ID: 2982389
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of neutrophil alkaline phosphatase (NAP) activity: untreated myeloid leukaemia, lymphoid leukaemia and normal humans.
Bendix-Hansen K; Helleberg-Rasmussen I
Scand J Haematol; 1985 Mar; 34(3):264-9. PubMed ID: 3857705
[TBL] [Abstract][Full Text] [Related]
17. Distinct alpha-L-fucosidase isoenzyme profiles in human leukemic cells.
Orlacchio A; Emiliani C; Rambotti P; Pioda GB; Davis S
Anticancer Res; 1988; 8(1):165-8. PubMed ID: 3162792
[TBL] [Abstract][Full Text] [Related]
18. Biochemical and immunologic analysis of hereditary myeloperoxidase deficiency.
Nauseef WM; Root RK; Malech HL
J Clin Invest; 1983 May; 71(5):1297-307. PubMed ID: 6189859
[TBL] [Abstract][Full Text] [Related]
19. Comparison of myeloperoxidase detection by flow cytometry using two different clones of monoclonal antibodies.
Leong CF; Kalaichelvi AV; Cheong SK; Hamidah NH; Rahman J; Sivagengei K
Malays J Pathol; 2004 Dec; 26(2):111-6. PubMed ID: 16329563
[TBL] [Abstract][Full Text] [Related]
20. Acquired neutrophil myeloperoxidase deficiency: an indicator of subclinical activation of blood coagulation?
d'Onofrio G; Mancini R; Vallone R; Alfano G; Candido A; Palla M; Mango G
Blood Cells; 1983; 9(3):455-66. PubMed ID: 6326898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
